| 216038 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control |
2015-11-04 |
10.1186/2051-1426-3-s2-p232 |
Lundqvist Andreas, Mao Yumeng, Zhang Xiaonan, Wennerberg Erik, Van Hoef Vincent, Larsson Ola, Linder Stig, Kiessling Rolf |
| 216037 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor hypoxia drives immune suppression and immunotherapy resistance |
2015-11-04 |
10.1186/2051-1426-3-s2-p392 |
Ai Midan, Budhani Pratha, Sheng Jie, Balasubramanyam Sadhana, Bartkowiak Todd, Jaiswal Ashvin R, Ager Casey R, Haria Dhwani D, Curran Michael A |
| 216036 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors |
2015-11-04 |
10.1186/2051-1426-3-s2-p97 |
Luke Jason J, Spranger Stefani, Bao Riyue, Andrade Jorge, Gajewski Thomas F |
| 216035 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma |
2015-11-04 |
10.1186/2051-1426-3-s2-p44 |
Poschke Isabel, Flossdorf Michael, Faryna Marta, Bergmann Frank, Hassel Jessica, Strobel Oliver, Offringa Rienk |
| 216034 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immunotherapy with patient-specific antigens selection reduced the metastasis of a cervical cancer patient |
2015-11-04 |
10.1186/2051-1426-3-s2-p385 |
Han Yanyan, Long Jianting, Ye Sheng, Tao Ran, Wu Dongyun, Li Jin, Zhou Xiangjun |
| 216033 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Prevalence analysis of OX40-positive cell populations in solid tumors |
2015-11-04 |
10.1186/2051-1426-3-s2-p113 |
Ziai James, Frantz Gretchen, Zhang Liping, Kozlowski Cleopatra, Gilbert Houston, Smith Jacquelyn, Kowanetz Marcin, Kim Jeong M, Huseni Mahrukh |
| 216032 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab |
2015-11-04 |
10.1186/2051-1426-3-s2-p96 |
Koguchi Yoshinobu, Hoen Helena, Bambina Shelly, Rynning Michael, Fuerstenberg Richard, Feng Zipei, Fox Bernard, Bifulco Carlo, Curti Brendan D, Urba Walter, Milburn Christina, Korman Alan J, Bahjat Keith S |
| 216031 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer |
2015-11-04 |
10.1186/2051-1426-3-s2-p151 |
Ghamande Sharad, Mauro David, Price Cheryl, Wheatley Donna, Janik John, Khleif Samir N |
| 216030 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma |
2015-11-04 |
10.1186/2051-1426-3-s2-p19 |
Hall MacLean, Mullinax John, Royster Erica, Reagan Angela, Gonzalez Ricardo, Pimiento Jose, Pilon-Thomas Shari, Sarnaik Amod |
| 216029 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells |
2015-11-04 |
10.1186/2051-1426-3-s2-p72 |
Chang Alan L, Miska Jason, Wainwright Derek A, Dey Mahua, Qiao Jian, Pytel Peter, Han Yu, Zhang Lingjiao, Balyasnikova Irina V, Ahmed Atique U, Lesniak Maciej S |
